P160008/S035: HeartSine samaritan (SAM) Public Access Defibrillator (PAD) SAM 350P, SAM 360P and SAM 450P and Accessories
FDA’s recorded scope: a battery supplier manufacturing site change
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 9 FDA records to the applicant name HeartSine Technologies Ltd. 4 entries are PMA supplements. 5 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 27, 2025 to Jun 22, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MKJ appears in 9 of the 9 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P160008, with 9 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 207 Airport Rd. W., Belfast, BT3 9ED. Recorded on P160008/S035, decision dated Jun 22, 2026.
Automated External Defibrillators (Non-Wearable).
FDA’s recorded scope: a battery supplier manufacturing site change
FDA’s recorded scope: changes to the Pad-Pak packaging process
FDA’s recorded scope: the addition of a mechanical inspection fixture to the final assembly process
FDA’s recorded scope: modification of the manufacturing process to refine the assembly process for the AED case
FDA’s recorded scope: modification to two software applications used during the final test portion of the device manufacturing process
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 4 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 3 Class II, 1 Class III records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| HeartSine Technologies Ltd | Class III | Oct 7, 2026 | FDA | |
| HeartSine Technologies Ltd | Class II | Sep 16, 2026 | FDA | |
| HeartSine Technologies Ltd | Class II | Oct 29, 2025 | FDA | |
| HeartSine Technologies Ltd | Class II | Aug 6, 2025 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 20, 2026.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| HeartSine Technologies Ltd | PMA supplement | Jun 22, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | May 18, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | May 7, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Jan 8, 2026 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Dec 22, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Sep 29, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Sep 17, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Sep 2, 2025 | FDA | |
| HeartSine Technologies Ltd | PMA supplement | Aug 27, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.